Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori

Lancet. 2002 Aug 17;360(9332):547-8. doi: 10.1016/S0140-6736(02)09711-8.

Abstract

Helicobacter pylori eradication is the initial treatment of choice in localised low-grade gastric MALT (mucosa-associated lymphoid-tissue)-type lymphoma. We describe the natural course of seven patients who refused further oncological treatment for persistent lymphoma after successful eradication of H pylori. Despite persistent clonality, neither lymphoma progression nor high-grade transformation arose during a mean observation period of 34 (range 22-44) months. In view of the favourable course of these patients, a watch-and-wait strategy could be a valid approach to management of this disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Clarithromycin / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori*
  • Humans
  • Lymphoma, B-Cell, Marginal Zone / drug therapy*
  • Lymphoma, B-Cell, Marginal Zone / microbiology*
  • Male
  • Metronidazole / administration & dosage
  • Middle Aged
  • Neoplasm, Residual / drug therapy
  • Neoplasm, Residual / microbiology
  • Omeprazole / administration & dosage

Substances

  • Metronidazole
  • Clarithromycin
  • Omeprazole